See more : Ducon Infratechnologies Limited (DUCON.NS) Income Statement Analysis – Financial Results
Complete financial analysis of Sativa Growth International (SAGD) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Sativa Growth International, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- AtriCure, Inc. (ATRC) Income Statement Analysis – Financial Results
- Yangzhou Chenhua New Material Co., Ltd. (300610.SZ) Income Statement Analysis – Financial Results
- MSD Acquisition Corp. (MSDAW) Income Statement Analysis – Financial Results
- Airtificial Intelligence Structures, S.A. (AITLF) Income Statement Analysis – Financial Results
- Golden Energy Offshore Services AS (GEOS.OL) Income Statement Analysis – Financial Results
Sativa Growth International (SAGD)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.sativagrowth.com
About Sativa Growth International
South American Gold Corp. focuses on acquiring and operating cannabis and tech assets. It provides medical marijuana products. The company was formerly known as Grosvenor Explorations Inc. and changed its name to South American Gold Corp. in October 2010. South American Gold Corp. was founded in 2005 and is based in Las Vegas, Nevada.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 20.00K | 8.19K | 25.84K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 20.00K | 8.19K | 25.84K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 100.00% | 100.00% | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 188.83K | 481.73K | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 204.18K | 266.49K | 2.12M | 24.44K | 27.39K | 39.49K | 74.18K |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 29.54K | 71.43K | 123.54K | 204.18K | 266.49K | 2.12M | 24.44K | 27.39K | 39.49K | 74.18K |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 29.54K | 71.43K | 123.54K | 249.87K | 456.98K | 2.60M | -24.61K | 27.39K | 44.49K | 80.63K |
| Cost & Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 29.54K | 71.43K | 123.54K | 249.87K | 456.98K | 2.60M | -24.61K | 27.39K | 44.49K | 80.63K |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 6.11K | 6.60K | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 41.52K | 0.00 | 107.00K | 229.26K | 3.29K | 0.00 | 86.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 228.49K | 236.56K | 206.30K | 171.86K | 161.14K | 52.52K | 22.82K | 0.00 | 188.00 | 1.66K | 2.56M | 0.00 | 0.00 | 0.00 | 0.00 |
| EBITDA | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -77.54K | -124.91K | -232.22K | -250.28K | -454.00K | -1.32M | -24.52K | -27.39K | -44.49K | -80.63K |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -47.70% | -772.16% | -378.10% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -9.54K | -63.24K | -97.70K | -278.87K | -461.77K | -3.88M | 24.61K | -27.39K | -44.49K | -80.63K |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -47.70% | -772.16% | -378.10% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -109.52K | -61.67K | -241.52K | -229.86K | 2.82K | -1.27M | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Before Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -119.06K | -124.91K | -339.22K | -479.73K | -466.57K | -5.16M | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -595.31% | -1,525.15% | -1,312.76% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -52.52K | -22.82K | 0.00 | 229.26K | 1.97K | -1.53M | 24.52K | 27.39K | 44.49K | 80.63K |
| Net Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -119.06K | -124.91K | -339.22K | -479.73K | -458.95K | -3.63M | -24.52K | -27.39K | -44.49K | -80.63K |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -595.31% | -1,525.15% | -1,312.76% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -7.83 | -11.59 | -45.43 | -0.23 | -0.26 | -0.42 | -0.76 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -7.83 | -11.59 | -45.43 | -0.23 | -0.26 | -0.42 | -0.76 |
| Weighted Avg Shares Out | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 677.35M | 652.35M | 107.85M | 61.30K | 39.61K | 79.81K | 107.11K | 106.05K | 106.05K | 106.05K |
| Weighted Avg Shares Out (Dil) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 652.35M | 107.85M | 61.30K | 39.61K | 79.81K | 107.11K | 106.05K | 106.05K | 106.05K |
Source: https://incomestatements.info
Category: Stock Reports